Document Type and Number:
Japanese Patent JPH0150207
Kind Code:
B2
Abstract:
A combination of an aromatase-inhibitor and an antiandrogen in a weight ratio of aromatase-inhibitor to antiandrogen of 20:1 to 1:1 is useful in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia. The aromatase-inhibitor is, for example, testolactone and the antiandrogen is, for example, cyproterone acetate.
Inventors:
HANSUUDO SHUAIKERUTO
URUFU TSUN
TEODOORU ZENGE
FURIITOMUNTO NOIMAN
URUFU TSUN
TEODOORU ZENGE
FURIITOMUNTO NOIMAN
Application Number:
JP12785781A
Publication Date:
October 27, 1989
Filing Date:
August 17, 1981
Export Citation:
Assignee:
SCHERING AG
International Classes:
A61K31/365; A61K31/565; A61K31/57; A61K45/06; A61P13/02; A61P15/00; C07J7/00; C07J63/00
Next Patent: JPH0150208